Clinical Study

Individualized Treatment For Nasopharyngeal Cancer Based On The Patient’S Dna

Posted Date: May 16, 2017

  • Investigator: Kevin Redmond
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This study is being done to see how people with your type of cancer respond to different types or levels of chemotherapy, based on a specific viral marker in their blood. This viral marker is called the Epstein Barr virus, (EBV). A more individualized approach to treating your type of cancer might be found using this blood marker.


To Be Eligible For This Study, Patients Must Have Nasopharyngeal Cancer (In The Head And Neck Region Of Your Body) That Has Not Spread To Other Parts Of Your Body


Nrg-Hn001, Nasopharyngeal Carcinoma, Cancer, Head & Neck, Null

For More Information:

Uc Cancer Institute